US 8779095
LAT adapter molecule for enhanced T-cell signaling and method of use
granted A61KA61K2239/55A61K2239/57
Quick answer
US patent 8779095 (LAT adapter molecule for enhanced T-cell signaling and method of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2239/55, A61K2239/57, A61K38/00, A61K40/11